Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
28.85
+2.09 (7.81%)
At close: Aug 26, 2026, 4:00 PM EDT
28.33
-0.52 (-1.80%)
After-hours: Aug 26, 2026, 7:41 PM EDT

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2102869119123359
Market Cap Growth
230.04%-59.65%-42.03%-2.89%-65.85%-5.17%
Enterprise Value
19514468183295
Last Close Price
28.859.1632.7079.2085.50339.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
5.571.017.4421.7098.5324.04
PB Ratio
65.311.053.953.211.875.49
P/TBV Ratio
90.731.053.953.211.875.49

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
5.190.504.9714.7266.7519.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.330.160.510.400.290.15
Net Debt / Equity Ratio
-6.21-0.91-0.83-0.92-0.87-0.83
Net Debt / EBITDA Ratio
0.150.940.350.661.081.28
Net Debt / FCF Ratio
0.291.100.400.851.361.37
Asset Turnover
1.060.740.200.070.010.16
Quick Ratio
1.072.641.782.966.615.28
Current Ratio
1.252.741.843.016.685.35
Return on Equity (ROE)
-1603.48%-121.11%-149.03%-98.73%-80.82%-61.16%
Return on Assets (ROA)
-172.66%-44.56%-55.47%-42.53%-38.29%-29.87%
Return on Capital Employed (ROCE)
-1039.60%-92.30%-224.80%-117.00%-67.10%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-78.30%-95.47%-58.90%-42.59%-43.21%-12.29%
FCF Yield
-23.94%-78.47%-52.71%-33.55%-34.22%-11.07%
Buyback Yield / Dilution
-84.06%-68.18%-23.11%-28.35%-13.95%-9.05%
SEC Filings: 10-K · 10-Q